Cationic lipids and polymers mediated vectors for delivery of siRNA
- PMID: 17716771
- DOI: 10.1016/j.jconrel.2007.07.016
Cationic lipids and polymers mediated vectors for delivery of siRNA
Abstract
RNA interference (RNAi) is one of the most importantly protective phenomena forming from the process combating against virus. Since its high efficiency for silencing the expression of proteins at the posttranscriptional level, RNAi shows great prospect in therapeutics for diseases. However, the delivery of siRNA into cells, tissues or organs remains to be a big obstacle for its applications. Many vectors for siRNA delivery have been developed including viral vectors and non-viral vectors, among them non-viral vectors have the advantages of low toxicity, ease of synthesis and low immune response over viral ones. Cationic liposomes and polymer particles, major varieties of non-viral vectors, used for gene delivery, have shown to be suitable for the delivery of siRNA. Based on the concise introduction of RNAi, this article reviews the non-viral delivery systems of siRNA, hoping to provide helpful information for the development of delivery systems of siRNA, and to summarize literatures about siRNA delivery published in recent years.
Similar articles
-
Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):164-82. doi: 10.1016/j.addr.2007.03.010. Epub 2007 Mar 21. Adv Drug Deliv Rev. 2007. PMID: 17481774 Review.
-
Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.Curr Opin Investig Drugs. 2008 Dec;9(12):1317-23. Curr Opin Investig Drugs. 2008. PMID: 19037838 Review.
-
SiRNA delivery: challenges and role of carrier systems.Pharmazie. 2011 May;66(5):313-8. Pharmazie. 2011. PMID: 21699063 Review.
-
Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.Gene Ther. 2007 Mar;14(5):459-64. doi: 10.1038/sj.gt.3302878. Epub 2006 Oct 19. Gene Ther. 2007. PMID: 17051250
-
Efficient and targeted delivery of siRNA in vivo.FEBS J. 2010 Dec;277(23):4814-27. doi: 10.1111/j.1742-4658.2010.07904.x. FEBS J. 2010. PMID: 21078116 Review.
Cited by
-
MicroRNA delivery for regenerative medicine.Adv Drug Deliv Rev. 2015 Jul 1;88:108-22. doi: 10.1016/j.addr.2015.05.014. Epub 2015 May 27. Adv Drug Deliv Rev. 2015. PMID: 26024978 Free PMC article. Review.
-
Fabrication of electrospun zein nanofibers for the sustained delivery of siRNA.J Mater Sci Mater Med. 2015 Feb;26(2):101. doi: 10.1007/s10856-015-5439-x. Epub 2015 Feb 6. J Mater Sci Mater Med. 2015. PMID: 25655500
-
An influenza virus-inspired polymer system for the timed release of siRNA.Nat Commun. 2013;4:1902. doi: 10.1038/ncomms2905. Nat Commun. 2013. PMID: 23695696
-
Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach.Int J Nanomedicine. 2019 May 2;14:3111-3128. doi: 10.2147/IJN.S200253. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31118626 Free PMC article. Review.
-
Role of Metastasis-Related microRNAs in Prostate Cancer Progression and Treatment.Cancers (Basel). 2021 Sep 6;13(17):4492. doi: 10.3390/cancers13174492. Cancers (Basel). 2021. PMID: 34503302 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources